Search Results 2691-2700 of 13406 for monoclonal antibody
Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...
UP-NEXT is a double-blind, randomized, placebo controlled study of the antibody-drug conjugate (ADC) XMT-1536 (upifitamab rilsodotin) administered as an ...
Patients who are known hepatitis C virus antibody positive (HCV Ab+) who have controlled infection (undetectable HCV RNA by PCR either spontaneously or in ...
About this study. The purpose of this study is to demonstrate the relationship between dd-cfDNA levels and HLA antibodies in blood transplant recipient and ...
For various rare immunobullous diseases, detection of a circulating autoantibody is necessary for accurate diagnosis. As a CLIA requirement, every clinical ...
... antibodies are allowed provided they do not have active disease requiring antiviral therapy). 10. Myocardial infarction within 6 months before enrollment ...
... antibody. 13. Participants with SSc: Pulmonary arterial hypertension requiring treatment, rapidly progressive or severe SSc gastrointestinal involvement, or ...
Galanis and her colleagues began to explore ways to strengthen this immune response to cancer. They combined the measles virus with anti-PD-1, an antibody that ...
Participation eligibility · < 5 half-lives or 14 days, whichever is longer, for any investigational agent; · < 28 days for any antibodies or biological therapies; ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.